Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Clara Peña is active.

Publication


Featured researches published by Clara Peña.


Biochemical Pharmacology | 1990

Chrysin (5,7-di-OH-flavone), a naturally-occurring ligand for benzodiazepine receptors, with anticonvulsant properties.

Jorge H. Medina; A.C. Paladini; Claudia Wolfman; Miguelina Levi de Stein; Daniel J. Calvo; Luis Diaz; Clara Peña

Chrysin (5,7-di-OH-flavone) was identified in Passiflora coerulea L., a plant used as a sedative in folkloric medicine. Chrysin was found to be a ligand for the benzodiazepine receptors, both central (Ki = 3 microM, competitive mechanism) and peripheral (Ki = 13 microM, mixed-type mechanism). Administered to mice by the intracerebroventricular route, chrysin was able to prevent the expression of tonic-clonic seizures induced by pentylenetertrazol. Ro 15-1788, a central benzodiazepine receptor antagonist, abolished this effect. In addition, all of the treated mice lose the normal righting reflex which suggests a myorelaxant action of the flavonoid. The presence in P. coerulea of benzodiazepine-like compounds was also confirmed.


Journal of Ethnopharmacology | 1994

Isolation of pharmacologically active benzodiazepine receptor ligands from Tilia tomentosa (Tiliaceae).

Haydee Viola; Claudia Wolfman; M.Levi de Stein; Cristina Wasowski; Clara Peña; Jorge H. Medina; A.C. Paladini

Tilia species are traditional medicinal plants widely used in Latin America as sedatives and tranquilizers. For this purpose, the infusion of their inflorescences is used to prepare a tea. In this study extracts of inflorescences from Tilia tomentosa Moench, one of the species found in the market, were purified using a benzodiazepine (BZD) binding assay to detect BZD receptor ligands in the different fractions. One of the ligands was identified as kaempferol, but it had low affinity (Ki = 93 microM) for this receptor, and did not produce sedative or anxiolytic effects in mice. On the other hand, a complex fraction, containing as yet unidentified constituents, but probably of a flavonoid nature, when administered intraperitoneally in mice, had a clear anxiolytic effect in both the elevated plus-maze and holeboard tests, two well validated pharmacological tests to measure anxiolytic and sedative compounds. This active fraction had no effect on total and ambulatory locomotor activity. In conclusion, our results demonstrate the occurrence of active principle(s) in, at least, one species of Tilia that may explain its ethnopharmacological use as an anxiolytic.


Biochemical and Biophysical Research Communications | 1989

Benzodiazepine-like molecules, as well as other ligands for the brain benzodiazepine receptors, are relatively common constituents of plants.

Jorge H. Medina; Clara Peña; M. Levi de Stein; Claudia Wolfman; A.C. Paladini

The presence of benzodiazepine (BZD)-like molecules as well as of other substances with affinity for the brain BZD-receptors was explored in eight non-flowering plants known to contain biflavonoids, three flowering plants used as sedatives in folkloric medicine and one plant extensively used in Argentina, Uruguay, Brazil and Paraguay as a tea substitute. All the plants examined contained substances which bound to the central BZD-receptors and the majority of them also had BZD-like compounds detected by their specific interaction with a monoclonal antibody against BZDs. In various cases this last type of compound was present in amounts which exceeded trace levels (0.5-1.0 ng/g). The biological or clinical significance for humans of all these substances should be explored.


International Immunopharmacology | 2011

Autoimmune hepatitis-like disease in C57BL/6 mice infected with mouse hepatitis virus A59

José L. Aparicio; Clara Peña; Lilia A. Retegui

Abstract Mouse hepatitis virus A59 (MHV A59) induces autoantibodies (autoAb) to fumarylacetoacetate hydrolase (FAH), a soluble cytosolic enzyme present in the liver and kidneys, in various mouse strains. The aim of this work was to amplify and diversify the autoimmune response restricted to FAH through the use of the exogenous adjuvant called PADRE. Accordingly, C57BL/6 mice were chosen, because these animals respond to PADRE better than other mouse strains. Results presented herein indicate that, surprisingly, C57BL/6 mice developed signs of autoimmune hepatitis-like disease (AIH), including transient hypergammaglobulinemia, elevated transaminases, autoAb directed against different liver proteins and hepatic cellular infiltrates, indicating that a new model of experimental AIH could be generated by a viral inoculation. Furthermore, PADRE administration amplified the MHV effect, extending the duration of hypergammaglobulinemia and increasing the binding of autoAb as well as the degree of hepatic infiltrates. However, the adjuvant did not expand the time of the symptoms. Additionally, since plasmatic uric acid and high-mobility group box protein 1 (HGMB1) concentrations augmented in MHV- and/or PADRE-treated mice, it is suggested that both alarmins were probably involved in the spreading of the immune response induced by the viral infection and the adjuvant administration.


Biochemical and Biophysical Research Communications | 1991

Naturally occurring benzodiazepines in human milk.

Clara Peña; Jorge H. Medina; Marta Piva; L.E. Diaz; C. Danilowicz; A.C. Paladini

The presence of benzodiazepine-like molecules was detected radioimmunologically in the plasma and milk of 12 women and in the plasma of 9 men. All subjects were non-users of benzodiazepines. The concentration of these biological materials expressed as diazepam equivalents per mL amounted to 2.54 +/- 0.74 ng in male plasma; to 2.20 +/- 0.35 ng in female plasma and to 1.91 +/- 0.54 ng in milk. Further investigation of the active compounds in milk permitted the unequivocal identification of diazepam, both free and bound to a presumably protein carrier and, at least, three more benzodiazepine-like molecules. Their origin either from dietary sources or as a result of endogenous biosynthesis is still unclear.


Biochemical and Biophysical Research Communications | 1991

Formation of benzodiazepine-like molecules in rat brain

Marta Piva; Jorge H. Medina; Angel L. de Blas; Clara Peña

The possible biosynthetic origin of benzodiazepine-like molecules was investigated in mammalian tissue. Rat brain homogenates or cortical slices incubated under physiological conditions showed a 4 to 7 fold increase in the content of BZD-like compounds as compared with control non incubated or boiled tissue. The quantitative analysis was performed by a radioimmunoassay with a specific monoclonal antibody. The active fraction eluting just before diazepam exhibited a Mr lower than 1300 and inhibited the [3H]flunitrazepam binding to the central benzodiazepine receptor. No activity was measured in the absence of tissue. These data suggest that under our experimental conditions, low molecular weight substances similar to benzodiazepines are formed in rat brain.


Neurochemistry International | 1997

Involvement of histidine 134 in the binding of α-bungarotoxin to the nicotinic acetylcholine receptor

Graciela Delia Venera; Fernando D Testai; Clara Peña; Hugo D. Lacorazza; Mirtha J. Biscoglio de Jimenez Bonino

Peptides corresponding to the sequence alpha 124-147 of the Torpedo californica and Homo sapiens nicotinic cholinergic receptors were synthesized. The His residue at position 134 was ethoxyformylated or substituted by Ala. Effects of such modifications were studied by: (a) a toxin blot assay and (b) a competition assay between each peptide and the Discopyge Ischudii receptor for 125I alpha-bungarotoxin, in solution. Apparent Kd values were 0.1 and 0.8 microM for Torpedo californica and Homo sapiens native peptides, respectively, and no binding was observed when the His residue was modified or substituted by Ala. ic50 values for the Torpedo californica and Homo sapiens fragments were 1.0 and 0.8 microM, respectively, and no significant displacement occurred when His 134 was ethoxyformylated or substituted by Ala. Hydroxylamine treatment restored 80-100% of their binding ability. Results strongly support the involvement of His 134 in the binding of alpha-bungarotoxin either to the Torpedo californica or the Homo sapiens receptor.


Molecular Neurobiology | 1992

Benzodiazepines in the brain. Their origin and possible biological roles.

Jorge H. Medina; Clara Peña; M. Piva; Claudia Wolfman; M. L. de Stein; Cristina Wasowski; C.R. da Cunha; Ivan Izquierdo; A.C. Paladini

Great progress has been made in the last 5 yr in demonstrating the presence of benzodiazepines (BDZs) in mammalian tissues, in beginning studies on the origin of these natural compounds, and in elucidating their possible biological roles. Many unanswered questions remain regarding the sources and biosynthetic pathways responsible for the presence of BDZs in brain and their different physiological and/or biochemical actions. This essay will focus on recent findings supporting that: (1) BDZs are of natural origin; (2) mammalian brain contains BDZs in concentrations ranging between 5.10−10–10−8M; (3) dietary source of BDZs might be a plausible explanation for their occurrence in animal tissues, including man; (4) the formation of BDZ-like molecules in brain is a possibility, experimentally supported; (5) BDZ-like molecules including diazepam andN-desmethyldiazepam are elevated in hepatic encephalopathy; and (6) natural BDZs in the brain are involved in the modulation of memory processes. Future studies using the full range of biochemical, physiological, behavioral, and molecular biological techniques available to the neuroscientist will hopefully continue to yield exciting and new information concerning the biological roles that BDZs might play in the normal and pathological functioning of the brain.


Peptides | 2005

Synthesis and biological properties of chimeric interferon-α2b peptides

Clara Peña; Viviana C. Blank; Verónica J. Marino; Leonor P. Roguin

We have previously reported the antiproliferative activity of synthetic sequences 29-35 and 122-139 of the interferon-alpha2b (IFN-alpha2b), both probably representing a common receptor recognition domain. In the search of new peptidic agonists, we designed and synthesized the linear peptide (Gly)2-122-137-Gly138-Gly29-30-35-(Gly)2, in which Gly residues replaced the 138 and 29 Cys bound through a disulfide bridge in the native cytokine. Additionally, a cyclic analog was obtained by reaction of the N- and C-terminal ends of the linear fragment. Thus, the distance that separates residues 122 and 35 in the crystalline structure of the IFN-alpha2b was maintained through a (Gly)4 bridge. When the influence of chimeric peptides on the proliferation of WISH cells was studied, it was shown that both derivatives significantly diminished cell growth. A more evident inhibitory effect on (125)I-IFN-alpha2b binding to WISH cell-membrane receptors was observed for both peptides. Results indicated that chimeric IFN-alpha2b peptides behaved as partial agonists of the IFN-alpha2b molecule and may be of interest for drug design purposes.


Immunological Investigations | 2007

Properties of cryptic epitopes and their corresponding antibodies as indicated by the study of human and ovine growth hormones.

Me Loureiro; Vj Marino; Paul Mathieu; M. Duhalde; Leonor P. Roguin; Clara Peña; Lilia A. Retegui

Antibodies (Ab) directed to hidden antigenic determinants (cryptotopes) are undesirable because they are not neutralizing. Additionally, we have previously demonstrated a close association between the extent of Ab to cryptic determinants and the expression of autoantibodies (autoAb) under some experimental conditions. Thus, the first objective of this work was to establish the physicochemical characteristics of Ab to cryptotopes and the second one was to examine the structural features of cryptic epitopes themselves. Using human and ovine growth hormones (hGH and oGH) as antigenic models and competition ELISA under different conditions of temperature, pH or ionic strength, we did not find any difference between the binding properties of anti-cryptic epitope antibodies (Ab) and anti-native epitope Ab. Then, using synthetic peptides and tryptic digests and direct and competition ELISAs we studied the structures of cryptic hGH and oGH epitopes. Isolated peptides either in solution or adsorbed on microplates failed to react. Partially digested hGH was recognized only when insolubilized on microplates, and anti-oGH Ab only reacted with a large fragment of the hormone either in solution or insolubilized. These results indicate that, at least in the case of hGH and oGH, cryptic epitopes are not simple linear sequences, as commonly referred without any evidence, but new exposed conformational structures different from those found in the native antigen.

Collaboration


Dive into the Clara Peña's collaboration.

Top Co-Authors

Avatar

Jorge H. Medina

University of Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

A.C. Paladini

National Scientific and Technical Research Council

View shared research outputs
Top Co-Authors

Avatar

Lilia A. Retegui

National Scientific and Technical Research Council

View shared research outputs
Top Co-Authors

Avatar

Claudia Wolfman

University of Buenos Aires

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fernando D Testai

National Scientific and Technical Research Council

View shared research outputs
Top Co-Authors

Avatar

Graciela Delia Venera

National Scientific and Technical Research Council

View shared research outputs
Top Co-Authors

Avatar

Marta Piva

National Scientific and Technical Research Council

View shared research outputs
Top Co-Authors

Avatar

Carlos G. Belloc

National Scientific and Technical Research Council

View shared research outputs
Top Co-Authors

Avatar

Cristina Wasowski

National Scientific and Technical Research Council

View shared research outputs
Researchain Logo
Decentralizing Knowledge